Hans Edgar Bishop, CEO & President at Juno Therapeutics, Inc. (JUNO), sold 121,825 shares at $48.74 ($5.7M) on 2016-06-09, disclosed to the SEC on 2016-06-13.
Open-market sale of $5.7M JUNO by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.80 | 59,675 | $2.7M | 48.0% |
| 2 | $47.03 | 16,751 | $788K | 13.8% |
| 3 | $47.03 | 16,751 | $788K | 13.8% |
| 4 | $47.97 | 8,394 | $403K | 7.1% |
| 5 | $47.97 | 8,394 | $403K | 7.1% |
| 6 | $48.74 | 5,930 |
| $289K |
| 5.1% |
| 7 | $48.74 | 5,930 | $289K | 5.1% |
| Total | $46.72 avg | 121,825 | $5.7M | 100% |
| Filing → |
| JUNO | SELL | 2016-09-21 | $4.9M | — | Filing → |
| JUNO | SELL | 2016-09-09 | $1.4M | — | Filing → |
| JUNO | SELL | 2016-09-02 | $2.6M | — | Filing → |